Agios Pharmaceuticals (AGIO) Leases (2019 - 2025)
Historic Leases for Agios Pharmaceuticals (AGIO) over the last 7 years, with Q4 2025 value amounting to $30.5 million.
- Agios Pharmaceuticals' Leases fell 2897.69% to $30.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.5 million, marking a year-over-year decrease of 2897.69%. This contributed to the annual value of $30.5 million for FY2025, which is 2897.69% down from last year.
- According to the latest figures from Q4 2025, Agios Pharmaceuticals' Leases is $30.5 million, which was down 2897.69% from $33.6 million recorded in Q3 2025.
- In the past 5 years, Agios Pharmaceuticals' Leases registered a high of $82.2 million during Q1 2021, and its lowest value of $30.5 million during Q4 2025.
- In the last 5 years, Agios Pharmaceuticals' Leases had a median value of $58.5 million in 2023 and averaged $57.7 million.
- In the last 5 years, Agios Pharmaceuticals' Leases tumbled by 1005.69% in 2021 and then plummeted by 2897.69% in 2025.
- Agios Pharmaceuticals' Leases (Quarter) stood at $75.1 million in 2021, then decreased by 13.3% to $65.1 million in 2022, then fell by 16.46% to $54.4 million in 2023, then dropped by 21.19% to $42.9 million in 2024, then dropped by 28.98% to $30.5 million in 2025.
- Its Leases stands at $30.5 million for Q4 2025, versus $33.6 million for Q3 2025 and $36.8 million for Q2 2025.